Related Experiment Videos
Prenatal screening for cystic fibrosis: an updated perspective
R A Doherty1, L A Bradley, J E Haddow
1Foundation for Blood Research, Scarborough, ME 04070-0190, USA.
American Journal of Obstetrics and Gynecology
|February 1, 1997
Summary
Prenatal screening for cystic fibrosis identifies high-risk pregnancies in U.S. white populations. Further trials are recommended to integrate cystic fibrosis screening into routine prenatal care.
Area of Science:
- Medical Genetics
- Prenatal Diagnosis
- Public Health
Background:
- Cystic Fibrosis (CF) is a genetic disorder.
- Current prenatal screening methods have limitations.
- Identifying at-risk pregnancies is crucial for early intervention.
Purpose of the Study:
- To evaluate the effectiveness of prenatal screening for cystic fibrosis.
- To compare cystic fibrosis screening with screening for other conditions like Down syndrome and spina bifida.
- To assess the feasibility of incorporating cystic fibrosis screening into routine prenatal care.
Main Methods:
- Analysis of intervention trials conducted in Europe and the United States.
- Comparison of detection rates, false-positive rates, and positive predictive values with other prenatal screening programs.
Main Results:
- Prenatal screening for cystic fibrosis can identify over 60% of high-risk pregnancies in U.S. white populations.
- Screening demonstrates a similar detection rate to spina bifida and Down syndrome screening.
- It offers a lower false-positive rate and higher odds of an affected fetus upon positive result.
Conclusions:
- Prenatal screening for cystic fibrosis is effective and compares favorably to other screening programs.
- Larger-scale trials in the U.S. are encouraged to optimize program design and case management.
- This could pave the way for routine cystic fibrosis screening in prenatal care.